Oaktree Acquisition III Life Sciences EBITDA 2025-2024 | OACC
Oaktree Acquisition III Life Sciences ebitda from 2025 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Oaktree Acquisition III Life Sciences Annual EBITDA (Millions of US $) |
Oaktree Acquisition III Life Sciences Quarterly EBITDA (Millions of US $) |
2024-09-30 |
|
Sector |
Industry |
Market Cap |
Revenue |
|
|
$0.224B |
$0.000B |
Oaktree Acquisition Corp. III Life Sciences is a blank check company. It formed for the purpose of entering into a combination with one or more businesses or entities. Oaktree Acquisition Corp. III is based in LOS ANGELES.
|